Experts discuss the effect and safety of lomitapide and evinacumab in treating patients with HoFH. Erin Michos, MD, MHS: Lomitapide [Juxtapid] is an oral microsomal transfer protein inhibitor. It’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results